搜索筛选:
搜索耗时2.5020秒,为你在为你在102,285,761篇论文里面共找到 14 篇相符的论文内容
发布年度:
[会议论文] 作者：Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
...
HBe Ag status determines the relationship between HBV DNA viral load and liver inflammation and fibr
[会议论文] 作者：Han Bai,Hongbo Liu,Can Xu,Xiaoguang Dou,
来源：14th international symposium on viral hepatitis and liver di 年份：2012
...
[会议论文] 作者：Han Bai,Lanzhu Gao,Chao Han,Xiaosong Qin,Jingyan Wang,Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:With the successfully inoculation of hepatitis B vaccine in the newborns,HBsAg carrier rate have significantly decreased during the past ten years in China.However,little is known about the...
Efficacy and Safety of Telbivudine in Preventing HBV Mother-to-Child Transmission in HBV-infected Pr
[会议论文] 作者：Qiuju Sheng,Yang Ding,Han Bai,Jingyan Wang,Chong Zhang,Lianrong Zhao,Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
...
Efficacy and Safety of Telbivudine in Preventing HBV Mother-to-Child Transmission in HBV-infected Pr
[会议论文] 作者：Qiuju Sheng,Yang Ding,Han Bai,Jingyan Wang,Chong Zhang,Lianrong Zhao,Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:To determine the serological and virological characteristics of pregnant women infected with hepatitis B virus(HBV),and valuate the efficacy and safety of telbivudine(LdT) for preventing HB...
Durability of HBeAg Seroconversion of Telbivudine as Monotherapy and as Combination Therapy with Ade
[会议论文] 作者：Qiuju Sheng,Chong Zhang,Jingyan Wang,Yang Ding,Xiaoguang Dou,Lilan Shi,Mingxiang Zhang,Feng Wu,Baojun,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
...
Durability of HBeAg Seroconversion of Telbivudine as Monotherapy and as Combination Therapy with Ade
[会议论文] 作者：Ding,Chong Zhang,Qiuju Sheng,Mingxiang Zhang,Feng Wu,Baojun Song,Weili Zhu,Jingyan Wang,Lilan Shi,Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:The EFFORT study have concluded that adjusting treatment strategy is recommended for suboptimal virological responders to telbivudine(LdT) at week 24,adding on adefovir(ADV) can benefit the...
[期刊论文] 作者：Zhang,Bingliang Lin,Shiwen Wang,Zhansheng Jia,Jingjun Wang,Jing Liu,Shuangsuo Dang,Yingren Zhao,Xiaoguang Dou,
来源： 年份：2022
...
Response to Entecavir(ETV)in patients with Chronic Hepatitis B(CHB)and primary non-response to Adefo
[会议论文] 作者：Qian,Weini Ou,Jun Cheng,Yuanbin Zhong,Lunli Zhang,Mingliang Cheng,Mao Mu,Maorong Wang,Zhiguo Yang,Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
...
Response to Entecavir(ETV)in patients with Chronic Hepatitis B(CHB)and primary non-response to Adefo
[会议论文] 作者：Qingchun Fu,Xiaojin Wang,Qing Xie,Jun Cheng,Lunli Zhang,Mingliang Cheng,Maorong Wang,Xiaoguang Dou,Junqi,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:Elevated HBV DNA levels are associated with increased risk for liver cancer and cirrhosis.Rapid and complete viral suppression correlates with lower rate of resistance development.Effective...
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of H
[期刊论文] 作者：Niu,Jia Shang,Wen Xie,Yuexin Zhang,Xun Li,Hong Ren,Hong Tang,Huiguo Ding,Xihong Wang,Yuemin Nan,Xiaoguang Dou,
来源：临床与转化肝病杂志（英文版） 年份：2019
Background and Aims: Chronic hepatitis B virus(HBV)in-fection remains a major public health problem globally.Here,we describe the baseline characteristics and t...
Entecavir Monotherapy Versus Entecavir Plus Adefovir Dipivoxil Combotherapy in Partial Responders wi
[会议论文] 作者：Xieer Liang,Jia Shang,Jun Cheng,Qing Xie,Xiaoguang Dou,Jifang Sheng,Long Xu,Junqi Niu,Deming Tan,Xiaoping,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:To investigate the efficacy and safety of entecavir monotherapy or entecavir plus adefovir dipivoxil combotherapy in partial responders with CHB....
Elderly women had higher risk of HBV induced cirrhosis:evidence from China Registry of Hepatitis B(C
[会议论文] 作者：Hong You,Yuanyuan Kong,Jinlin Hou,Lai Wei,Yuexin Zhang,Junqi Niu,Tao Han,Xiaojuan Ou,Xiaoguang Dou,Jia,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:Male sex and advancing age are known factors associated with chronic hepatitis B disease progression and cirrhosis.However,few studies have explored the risk of the elderly women for HBV-as...
Baseline Quantitative Hepatitis B Core Antibody Titer Alone Strongly Predicts HBeAg Seroconversion a
[会议论文] 作者：Guangfeng Shi,Hao Wang,Deming Tan,Mobin Wan,Shijun Chen,Min Xu,Xinyue Chen,Hong Tang,Jifang Sheng,Xiaoguang Dou,
来源：2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份：2014
Background:The investigation regarding the clinical significance of quantitative hepatitis B core antibody(anti-HBc) during chronic hepatitis B(CHB) treatment is few....
相关搜索：
